Geremia B. Bolli

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Mauro Lepore, Simone Pampanelli, Carmine G. Fanelli et al. · Diabetes · 2000 · 820 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion

Geremia B. Bolli, Pierpaolo De Feo, P. Compagnucci et al. · Diabetes · 1983 · 406 citations

Medicine, Endocrinology, Internal Medicine +15

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Matthew C. Riddle, Geremia B. Bolli, M. Ziemen et al. · Diabetes Care · 2014 · 360 citations

Medicine, Endocrinology, Pharmacotherapy +17

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3)

Geremia B. Bolli, Matthew C. Riddle, Richard M. Bergenstal et al. · Diabetes Obesity and Metabolism · 2015 · 298 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus

Paolo Gresele, Giuseppe Guglielmini, Massimiliano De Angelis et al. · Journal of the American College of Cardiology · 2003 · 278 citations

Medicine, Endocrinology, Hematology +16